go back

ASXL1 Gene Test for Bone Marrow Disorders

Delaware rates for HCPCS 81175

A laboratory test that examines the ASXL1 gene in a blood or bone marrow sample for changes associated with disorders of the bone marrow, including myelodysplastic syndromes and certain leukemias. Findings help confirm a diagnosis and give a sense of how the disease is likely to behave. Results are read alongside the blood counts, marrow findings, and other testing.

Rates data updated July 2026.

Facilitymedian $776 · 10th–90th $776$7760%50%$776Professionalmedian $457 · 10th–90th $372$2,0420%20%10th90th$457$500.0$1.0K$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$776.25
Median
$776.25
Typical High
$776.25
Aetna
Setting
Professional
Modifier
Global
Typical Low
$371.54
Median
$457.09
Typical High
$2,041.74
Cigna
Setting
Facility
Modifier
Global
Typical Low
$436.52
Median
$436.52
Typical High
$436.52
Cigna
Setting
Professional
Modifier
Global
Typical Low
$302.00
Median
$346.74
Typical High
$954.99
United
Setting
Professional
Modifier
Global
Typical Low
$288.40
Median
$426.58
Typical High
$1,023.29